Cipla Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cipla Ltd with three other
companies in this sector in India:
Aurobindo Pharma Ltd
sales of 81.00 billion Indian Rupees [US$1.35 billion]
Cadila Healthcare Ltd
(72.24 billion Indian Rupees [US$1.20 billion]
of which 100%
was ), and
Ranbaxy Laboratories Limited
(104.24 billion Indian Rupees [US$1.73 billion]
of which 125%
Cipla Ltd reported sales of 101.00 billion Indian Rupees (US$1.68 billion)
March of 2014.
increase of 22.9%
versus 2013, when the company's sales were 82.16 billion Indian Rupees.
Sales at Cipla Ltd have increased during each of the previous five years
(and since 2009, sales have increased a total of 104%).